Quality Indicators - ESGO Gynae-Oncology Guidelines Skip to content

Quality Indicators for the surgical treatment of endometrial carcinoma

 

Based on the ESGO-ESTRO-ESP Endometrial cancer guidelines developed from 2019-2020, 29 structural, process and outcome indicators were defined. They are related to center case olad, training, experience of the surgeon, structured multi-disciplinarity of the team and active participation in clinical research. Two  indicators ar related to the adequate pre-operative invetsigations, 14 to peri-operative standards of care. One indicator is related to molecular markeers for endometrial carcinoma diagnosis and determinants for treatment decisions. Another quality indicator is dedicated to the management of patients after primary surgical treatment and last five indicators highlight the need for a systematic assessment of surgical morbidity and oncologic outcome. An assessment form including a scoring systém was built as a basis for ESGO accreditation of centrs for endometrial cancer surgery.

The article was published in December 2021 and is available here: ESGO Quality Indicators for the surgical treatment of endometrial carcinoma

 

Working Group

Name Country Institution
Nicole Concin Germany Innsbruck Medical University (Austria), Evangelische kliniken Essen-Mitte
Jan Persson Sweden Skåne University Hospital, Lund University, Faculty of Medicine, Clinical Sciences, Lund
Nadeem Abu-Rustum United States Memorial Sloan Kettering Cancer Center, New York
Beyhan Ataseven Germany Evangelische kliniken Essen-Mitte, University Hospital Munich
David Cibula Czech Republic First Faculty of Medicine, General University Hospital of Charles University in Prague
Anna Fagotti Italy Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome
Christina Fotopoulou United Kingdom Imperial College London Faculty of Medicine, London
Pawel Knapp Poland University Oncology Center, Medical University of Bialystok
Christian Marth Austria Innsbruck Medical University
Philippe Morice France Institut Gustave Roussy, Villejuif, Paris
Denis Querleu France Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome (Italy), University Hospital Strasbourg
Jalid Sehouli Germany Campus Virchow Klinikum, Charite-Universtätsmedizin Berlin, Corporate Member of Freie Universität zu Berlin and Berlin Institute of Health, Berlin
Artem Stepanyan Armenia Nairi Medical Center, Yerevan
Cagatay Taskiran Turkey Koç University School of Medicine, Ankara, VKV American Hospital, Istanbul
Ignace Vergote Belgium Leuven Cancer Institute, Catholic University Leuven
Pauline Wimberger Germany Department of Gynecology and Obstetrics, Technische Universität Dresden, National Center for Tumour Diseases, Dresden, German Cancer Research Center, Heidelberg, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden,  Medizinische Fakultat Carl Gustav Carus, Dresden, Helmholtz-Zentrum Dresden-Rossendorf
Ignacio Zapardiel Spain La Paz University Hospital - IdiPAZ, Madrid

 

External reviewers

141 reviewers - 36 countries

ESGO would also like to thank external reviewers who have taken the time to provide their feedback on the document elaborated in the framework of the ESGO Quality Indicators for the surgical treatment of endometrial carcinoma.

List of external reviewers